IMMUNOTUNE Trademark

Trademark Overview


On Tuesday, November 30, 2021, a trademark application was filed for IMMUNOTUNE with the United States Patent and Trademark Office. The USPTO has given the IMMUNOTUNE trademark a serial number of 97149079. The federal status of this trademark filing is REQUEST FOR THIRD EXTENSION - FILED as of Sunday, April 21, 2024. This trademark is owned by Catalyst Biosciences, Inc.. The IMMUNOTUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services
immunotune

General Information


Serial Number97149079
Word MarkIMMUNOTUNE
Filing DateTuesday, November 30, 2021
Status720 - REQUEST FOR THIRD EXTENSION - FILED
Status DateSunday, April 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements


Goods and ServicesResearch and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 13, 2022
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameVERTEX PHARMACEUTICALS INCORPORATED
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOSTON, US 02210

Party NameCatalyst Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, US 94080

Party NameCatalyst Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, US 94080

Trademark Events


Event DateEvent Description
Friday, December 3, 2021NEW APPLICATION ENTERED
Saturday, December 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 8, 2022ASSIGNED TO EXAMINER
Tuesday, September 13, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 13, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, September 13, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 13, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, September 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 1 FILED
Thursday, June 8, 2023SOU EXTENSION 1 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 2 FILED
Monday, October 23, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, April 21, 2024SOU TEAS EXTENSION RECEIVED
Sunday, April 21, 2024SOU EXTENSION 3 FILED
Sunday, April 21, 2024SOU EXTENSION 3 GRANTED
Tuesday, April 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED